References

1.       The European Centre for Disease Prevention and Control. Data on 14-day notification rate of new COVID-19 cases and deaths [Internet]. 2020 [cited 28 Jan 2021]. https://www.ecdc.europa.eu/en/publications-data/data-national-14-day-notification-rate-covid-19
2.       Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int J Surg. 2020;78:185. https://doi.org/10.1016/j.ijsu.2020.04.018
3.       Chi Y-L, Regan L, Nemzoff C, Krubiner C, Anwar Y, Walker D. Beyond COVID-19: A Whole of Health Look at Impacts During the Pandemic Response. Policy Paper No. 117 [Report]. Washington DC: Center for Global Development; 2020 p. 1-19. https://www.cgdev.org/sites/default/files/PP177-Beyond-COVID-scoping-paper.pdf
4.       European Centre for Disease Prevention and Control. Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK –eighth update. Rapid Risk Assessment Report [Report]. Stockholm: ECDC; 2020 p. 1-21. https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-rapid-risk-assessment-coronavirus-disease-2019-eighth-update-8-april-2020.pdf
5.       World Health Organization Regional Office for Europe. COVID-19 weekly surveillance report: Data for the week of 20-26 July (Epi week 30) [Internet]. 2020 [cited 26 July 2020]. https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/weekly-surveillance-report
6.       Organisation for Economic Co-operation and Development. OECD Policy responses to coronavirus (COVID-19): Workforce and safety in long-term care during the COVID-19 pandemic. Updated 22 June 2020 [Report]. OECD; 2020 p. 1-5. http://www.oecd.org/coronavirus/policy-responses/workforce-and-safety-in-long-term-care-during-the-covid-19-pandemic-43fc5d50/
7.       London School of Hygiene & Tropical Medicine. One in five people globally could be at increased risk of severe COVID-19 disease through underlying health conditions [Internet]. 2020. [cited 23 Dec 2020].
https://www.lshtm.ac.uk/newsevents/news/2020/one-five-people-globally-could-be-increased-risk-severe-covid-19-disease
8.       Mikolai J, Keenan K, Kulu H. Household level health and socio-economic vulnerabilities and the COVID-19 crisis: An analysis from the UK. Epub ahead of print 2 May 2020. https://doi.org/10.31235/osf.io/4wtz8
9.       Gronvall G, Connell N, Kobokovich A, West R, Warmbrod KL, Shearer M, Inglesby T. Developing a National Strategy for Serology (Antibody Testing) in the United States [Report]. The Johns Hopkins Center for Health Security; 2020 p. 1-29. https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/2020/200422-national-strategy-serology.pdf
10.   European Centre for Disease Prevention and Control. Guidance on infection prevention and control of COVID-19 in migrant and refugee reception and detention centres in the EU/EEA and the UK – June 2020 [Report]. Stockholm: ECDC; 2020 p.1-17. https://www.ecdc.europa.eu/en/publications-data/covid-19-guidance-prevention-control-migrant-refugee-centres
11.   European Centre for Disease Prevention and Control. Guidance on the provision of support for medically and socially vulnerable populations in EU/EEA countries and the United Kingdom during the COVID-19 pandemic – July 2020 [Report]. Stockholm: ECDC; 2020 p.1-25. https://www.ecdc.europa.eu/sites/default/files/documents/Medically-and-socially-vulnerable-populations-COVID-19.pdf
12.   Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020;584(7820):257–61. https://doi.org/10.1038/s41586-020-2405-7.
13.   Organisation for Economic Co-operation and Development. OECD Policy responses to coronavirus (COVID-19): Evaluating the initial impact of COVID-19 containment measures on economic activity. Updated 10 June 2020 [Report]. OECD; 2020 p. 1-5. http://www.oecd.org/coronavirus/policy-responses/evaluating-the-initial-impact-of-covid-19-containment-measures-on-economic-activity-b1f6b68b/
14.   Reimers FM, Schleicher A. Schooling disrupted, schooling rethought. How the Covid-19 pandemic is changing education [Report]. OECD; 2020 p. 1-42. https://read.oecd-ilibrary.org/view/?ref=133_133390-1rtuknc0hi&title=Schooling-disrupted-schooling-rethought-How-the-Covid-19-pandemic-is-changing-education
15.   World Bank. World Bank Education and COVID-19. Update 30 April 2020 [Internet]. 2020 [cited 26 July 2020]. https://www.worldbank.org/en/data/interactive/2020/03/24/world-bank-education-and-covid-19
16.   World Health Organization Regional Office for Europe COVID-19 weekly surveillance report [Internet]. 2020 [cited 23 Dec 2020].  https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/weekly-surveillance-report
17.   Hamblin M. Is Everyone Depressed?. The Atlantic. 2020 May 22.  https://www.theatlantic.com/health/archive/2020/05/depression-coronavirus/611986
18.   World Health Organization. Substantial investment needed to avert mental health crisis [Internet]. 2020 [cited 23 Dec 2020].  https://www.who.int/news-room/detail/14-05-2020-substantial-investment-needed-to-avert-mental-health-crisis
19.   United Nations. Policy Brief: COVID-19 and the Need for Action on Mental Health [Internet]. 2020 [cited 23 Dec 2020].  https://www.un.org/sites/un2.un.org/files/un_policy_brief-covid_and_mental_health_final.pdf
20.   Chandan JS, Taylor J, Bradbury-Jones C, Nirantharakumar K, Kane E, Bandyopadhyay S. COVID-19: a public health approach to manage domestic violence is needed. Lancet Public Heal [Internet]. 2020 Jun 1;5(6):e309. https://doi.org/10.1016/S2468-2667(20)30112-2
21.   Organisation for Economic Co-operation and Development. OECD Policy responses to coronavirus (COVID-19): COVID-19 and International Trade: Issues and actions. Updated 12 June 2020 [Report]. OECD; 2020 p. 1-12. https://www.oecd.org/coronavirus/policy-responses/covid-19-and-international-trade-issues-and-actions-494da2fa/
22.   International Labour Organization. ILO Monitor: COVID-19 and the world of work. 5th Edition. Update 30 June 2020 [Report]. ILO; 2020 p. 1-22. https://www.ilo.org/global/topics/coronavirus/impacts-and-responses/WCMS_749399/lang--en/index.htm
23.   European Data Portal. The impact of COVID-19 on the International Tourism Industry [Internet]. 2020 [cited 23 Dec 2020].  https://www.europeandataportal.eu/en/covid-19/stories/impact-covid-19-international-tourism-industry
24.   Andrews A. The Coronavirus Recession is a “She-cession”. Institute for Women’s Policy Research. 2020 May 15. https://iwpr.org/media/press-hits/the-coronavirus-recession-is-a-she-cession/
25.   United Nations. Generations of progress for women and girls could be lost to COVID pandemic, UN chief warns. UN News. 2020 August 31. https://news.un.org/en/story/2020/08/1071372
26.   Yu H, Sun B, Fang Z, Zhao J, Liu X, Li Y, et al. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients. Eur Respir J [Internet]. 2020;56(6):2001526. https://doi.org/10.1183/13993003.01526-2020
27.   Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Spijker R, Taylor-Phillips S, et al. Antibody tests for identification of current and past infection with SARS‐CoV‐2. Cochrane Database Syst Rev. 2020;(6). https://doi.org/10.1002/14651858.CD013652
28.   Centers for Disease Control and Prevention. Interim Guidelines for COVID-19 Antibody Testing. Update 1 August 2020 [Internet]. 2020 [cited 23 Dec 2020]. https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html
29.   Van Caeseele P, Bailey D, Forgie SE, et al. SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health. Can Med Assoc J [Internet]. 2020;192(34):E973 LP-E979. https://doi.org/10.1503/cmaj.201588
30.   To KK-W, Hung IF-N, Ip JD, Chu AW-H, Chan W-M, Tam AR, et al. Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing. Clin Infect Dis [Internet]. 2020 Aug 25:ciaa1275. https://doi.org/10.1093/cid/ciaa1275
31.   Lei Q, Li Y, Hou H-Y, Wang F, Ouyang Z-Q, Zhang Y, et al. Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections. Allergy [Internet]. 2020 Oct 10:all.14622. https://doi.org/10.1111/all.14622
32.   Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan. Euro Surveill. 2020;25(10):pii=2000180. https://doi.org/10.2807/1560-7917.ES.2020.25.10.2000180
33.   Byambasuren O, Cardona M, Bell K, Clark J, McLaws M-L, Glasziou P. Estimating the extent of true asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. medRxiv. 2020.  https://doi.org/10.1101/2020.05.10.20097543.
34.   Spicuzza L, Montineri A, Manuele R, Crimi C, Pistorio MP, Campisi R, et al. Reliability and usefulness of a rapid IgM-IgG antibody test for the diagnosis of SARS-CoV-2 infection: A preliminary report. J Infect [Internet]. 2020;81(2):e53–54. https://doi.org/10.1016/j.jinf.2020.04.022
35.   Peeling RW, Wedderburn CJ, Garcia PJ, Boeras D, Fongwen N, Nkengasong J, et al. Serology testing in the COVID-19 pandemic response. Lancet Infect Dis [Internet]. 2020;20(9):e245–49. https://doi.org/10.1016/S1473-3099(20)30517-X
36.   Kuehn BM. Genetic Analysis Tracks SARS-CoV-2 Mutations in Human Hosts. JAMA [Internet]. 2020;323(23):2363. https://doi.org/10.1001/jama.2020.9825
37.   World Health Organization. Advice on the use of point-of-care immunodiagnostic tests for COVID-19: scientific brief - 8 April 2020 [Report]. Geneva: WHO; 2020 p. 1-3.  https://www.who.int/publications/i/item/advice-on-the-use-of-point-of-care-immunodiagnostic-tests-for-covid-19-scientific-brief
38.   European Commission. Current performance of COVID-19 test methods and devices and proposed performance criteria - Working document of Commission services – 6 April 2020 [Report]. European Commission; 2020 p. 1-30. https://ec.europa.eu/docsroom/documents/40805
39.   World Health Organization. (‎2020)‎. Diagnostic testing for SARS-CoV-2: interim guidance - 11 Sep 2020 [Report]. Geneva: WHO; 2020 p. 1-20. https://www.who.int/publications/i/item/diagnostic-testing-for-sars-cov-2
40.   European Commission. Coronavirus response: Public Health [Internet]. 2020 [cited 23 Dec 2020]. https://ec.europa.eu/info/live-work-travel-eu/health/coronavirus-response/public-health_en
41.   European Commission. Guidelines on COVID-19 in vitrodiagnostic tests and their performance. Brussels: European Commission; 2020 p. 1-20.  https://ec.europa.eu/info/sites/info/files/testing_kits_communication.pdf
42.   European Centre for Disease Prevention and Control. (April 09, 2020). Strategies for the surveillance of COVID-19. Technical Report - 9 April 2020 [Report]. Stockholm: ECDC; 2020 p. 1-6. https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-surveillance-strategy-9-Apr-2020.pdf
43.   Gronvall G., Connell N., Farley J.E., Ingleshby T., Jennings J., Mehta S., West R., Kobokovich A. Developing a National Strategy for SARS-CoV-2. Sero-surveys in the United States [Report]. The Johns Hopkins Center for Health Security; 2020 p. 1-32.  Available at: https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/2020/200618-sero-survey-strategy.pdf
44.   European Centre for Disease Prevention and Control. Immune responses and immunity to SARS-CoV-2 [Internet]. 2020 [cited 23 Dec 2020].  https://www.ecdc.europa.eu/en/covid-19/latest-evidence/immune-responses
45.   European Centre for Disease Prevention and Control. (June 15, 2020). Laboratory support for COVID-19 in the EU/EEA [Internet]. 2020 [cited 23 Dec 2020]. https://www.ecdc.europa.eu/en/novel-coronavirus/laboratory-support
46.   World Health Organization. Coronavirus disease (COVID-19) technical guidance: The Unity Studies: Early Investigations Protocols [Internet]. 2020 [cited 23 Dec 2020]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/early-investigations